Breath analysis by eNose technology represents a promising diagnostic tool in lung disease. The next step in making this technology suitable for multi-centre trials, such as the U-BIOPRED study, is to facilitate centralized (semi)-automatic measurements on multiple eNoses simultaneously.
To show how people with asthma are working with the European Lung Foundation (ELF) and patient organisations to effectively communicate the aims and achievements of the U-BIOPRED clinical trial to people with asthma and the public.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.